vs
ALUMIS INC.（ALMS）与AMERISERV FINANCIAL INC（ASRV）财务数据对比。点击上方公司名可切换其他公司
AMERISERV FINANCIAL INC的季度营收约是ALUMIS INC.的1.5倍（$3.9M vs $2.7M），ALUMIS INC.净利率更高（2225.1% vs 36.9%，领先2188.1%）
ALUMIS INC.是一家临床阶段生物制药企业，专注于研发针对自身免疫性疾病与炎症性疾病的创新靶向疗法，旗下多款核心候选产品处于临床试验阶段，致力于满足全球患者尚未被满足的医疗需求。
Ameriserv Financial Inc.是总部位于美国宾夕法尼亚州的区域金融服务控股公司，主要为当地个人消费者及中小企业提供零售与商业银行业务，包括存款、各类贷款及财富管理解决方案。
ALMS vs ASRV — 直观对比
营收规模更大
ASRV
是对方的1.5倍
$2.7M
净利率更高
ALMS
高出2188.1%
36.9%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.7M | $3.9M |
| 净利润 | $59.3M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -5271.5% | 43.0% |
| 净利率 | 2225.1% | 36.9% |
| 营收同比 | — | 2.4% |
| 净利润同比 | 205.0% | 62.2% |
| 每股收益（稀释后） | $0.77 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALMSASRV
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | $15.4M | ||
| Q2 25 | $2.7M | $14.5M | ||
| Q1 25 | $17.4M | $14.1M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | $13.1M | ||
| Q2 24 | — | $13.2M | ||
| Q1 24 | — | $13.7M |
净利润ALMSASRV
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | $59.3M | $-282.0K | ||
| Q1 25 | $-99.0M | $1.9M | ||
| Q4 24 | — | $889.0K | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $-375.0K | ||
| Q1 24 | — | $1.9M |
营业利润率ALMSASRV
| Q4 25 | — | 43.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | -5271.5% | -2.4% | ||
| Q1 25 | -583.9% | 17.0% | ||
| Q4 24 | — | 28.2% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | -3.7% | ||
| Q1 24 | — | 17.4% |
净利率ALMSASRV
| Q4 25 | — | 36.9% | ||
| Q3 25 | — | 16.5% | ||
| Q2 25 | 2225.1% | -1.9% | ||
| Q1 25 | -569.1% | 13.6% | ||
| Q4 24 | — | 23.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | 13.9% |
每股收益（稀释后）ALMSASRV
| Q4 25 | — | $0.09 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | $0.77 | $-0.02 | ||
| Q1 25 | $-1.82 | $0.12 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $486.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $485.3M | $119.3M |
| 总资产 | $610.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALMSASRV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $486.3M | — | ||
| Q1 25 | $208.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALMSASRV
| Q4 25 | — | $119.3M | ||
| Q3 25 | — | $114.6M | ||
| Q2 25 | $485.3M | $110.9M | ||
| Q1 25 | $168.3M | $110.8M | ||
| Q4 24 | — | $107.2M | ||
| Q3 24 | — | $108.2M | ||
| Q2 24 | — | $103.7M | ||
| Q1 24 | — | $103.9M |
总资产ALMSASRV
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $610.9M | $1.4B | ||
| Q1 25 | $261.3M | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.4M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-107.0M | — |
| 自由现金流率自由现金流/营收 | -4012.3% | — |
| 资本支出强度资本支出/营收 | 23.1% | — |
| 现金转化率经营现金流/净利润 | -1.79× | 2.21× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALMSASRV
| Q4 25 | — | $3.2M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | $-106.4M | $-62.0K | ||
| Q1 25 | $-80.4M | $599.0K | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | — | $-235.0K | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $-2.2M |
自由现金流ALMSASRV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-107.0M | — | ||
| Q1 25 | $-80.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ALMSASRV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -4012.3% | — | ||
| Q1 25 | -462.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ALMSASRV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ALMSASRV
| Q4 25 | — | 2.21× | ||
| Q3 25 | — | 0.55× | ||
| Q2 25 | -1.79× | — | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.02× | ||
| Q3 24 | — | -0.20× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -1.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALMS
暂无分部数据
ASRV
| Asset Management1 | $3.1M | 79% |
| Other | $838.0K | 21% |
